Coverage will likely include:
- Finding new ligases and mechanisms for targeted degradation
- Pursuing extracellular and hard-to-drug intracellular targets for degradation
- Novel screening assays, AI/ML to identify and optimize novel degraders/glues
- Studies looking at degradation of RNA, lipids as therapeutic options
The deadline for priority consideration is September 15, 2023.
All proposals are subject to review by session chairpersons and/or the Scientific Advisory Committee to ensure the overall quality of the conference program. Additionally, as per Cambridge Healthtech Institute’s policy, a select number of vendors and consultants who provide products and services will be offered opportunities for podium presentation slots based on a variety of Corporate Sponsorships.
We hope you can join us for the 5 concurrent day-and-a-half conferences during each half of our 19th Annual Drug Discovery Chemistry event. Registering for this conference lets you also move back and forth among parallel programs to create your own agenda.
Opportunities for Participation: